Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry.

Pellock JM, Faught E, Foroozan R, Sergott RC, Shields WD, Ziemann A, Lee D, Dribinsky Y, Torri S, Othman F, Isojarvi J.

Epilepsy Behav. 2016 Jul;60:174-80. doi: 10.1016/j.yebeh.2016.03.030.

PMID:
27208827
2.

Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin.

Krauss G, Faught E, Foroozan R, Pellock JM, Sergott RC, Shields WD, Ziemann A, Dribinsky Y, Lee D, Torri S, Othman F, Isojarvi J.

Epilepsy Behav. 2016 Mar;56:15-9. doi: 10.1016/j.yebeh.2015.12.004.

PMID:
26807550
3.

Unintended Consequences: The Story of PERF.

Elterman RD, Shields WD.

Pediatr Neurol. 2015 Sep;53(3):183-4. doi: 10.1016/j.pediatrneurol.2015.05.014. No abstract available.

PMID:
26149106
4.

Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation.

Kossoff EH, Shields WD.

Epilepsia. 2014 Sep;55 Suppl 4:29-33. doi: 10.1111/epi.12546. Review.

5.

Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone.

Hussain SA, Shinnar S, Kwong G, Lerner JT, Matsumoto JH, Wu JY, Shields WD, Sankar R.

Epilepsia. 2014 Jan;55(1):103-7. doi: 10.1111/epi.12460.

6.

Screening for suicidal ideation in children with epilepsy.

Jones JE, Siddarth P, Gurbani S, Shields WD, Caplan R.

Epilepsy Behav. 2013 Dec;29(3):521-6. doi: 10.1016/j.yebeh.2013.09.020.

7.

Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations.

Shields WD, Pellock JM.

Acta Neurol Scand Suppl. 2011;(192):1-4. doi: 10.1111/j.1600-0404.2011.01606.x. No abstract available.

PMID:
22061175
8.

Registry initiated to characterize vision loss associated with vigabatrin therapy.

Pellock JM, Faught E, Sergott RC, Shields WD, Burkhart GA, Krauss GL, Foroozan R, Wesche DL, Weinberg MA.

Epilepsy Behav. 2011 Dec;22(4):710-7. doi: 10.1016/j.yebeh.2011.08.034.

PMID:
21978471
9.

1H MRSI and social communication deficits in pediatric complex partial seizures.

O'Neill J, Seese R, Hudkins M, Siddarth P, Levitt J, Tseng PB, Wu KN, Gurbani S, Shields WD, Caplan R.

Epilepsia. 2011 Sep;52(9):1705-14. doi: 10.1111/j.1528-1167.2011.03114.x.

10.

Infantile spasms: a U.S. consensus report.

Pellock JM, Hrachovy R, Shinnar S, Baram TZ, Bettis D, Dlugos DJ, Gaillard WD, Gibson PA, Holmes GL, Nordl DR, O'Dell C, Shields WD, Trevathan E, Wheless JW.

Epilepsia. 2010 Oct;51(10):2175-89. doi: 10.1111/j.1528-1167.2010.02657.x. Review.

11.

Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy.

Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Erba G, Gardiner I, Stern J, Dewar S, Sperling MR, Jacobs M, Kieburtz K; Early Randomized Surgical Epilepsy Trial (ERSET) Study Group..

Epilepsia. 2010 Oct;51(10):1978-86. doi: 10.1111/j.1528-1167.2010.02641.x.

12.

Suicidality and brain volumes in pediatric epilepsy.

Caplan R, Siddarth P, Levitt J, Gurbani S, Shields WD, Sankar R.

Epilepsy Behav. 2010 Jul;18(3):286-90. doi: 10.1016/j.yebeh.2010.04.018.

PMID:
20494620
13.

Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: Short-term outcomes.

Jones JE, Siddarth P, Gurbani S, Shields WD, Caplan R.

Epilepsy Behav. 2010 Jul;18(3):211-7. doi: 10.1016/j.yebeh.2010.03.015.

14.

Improved outcomes in pediatric epilepsy surgery: the UCLA experience, 1986-2008.

Hemb M, Velasco TR, Parnes MS, Wu JY, Lerner JT, Matsumoto JH, Yudovin S, Shields WD, Sankar R, Salamon N, Vinters HV, Mathern GW.

Neurology. 2010 Jun 1;74(22):1768-75. doi: 10.1212/WNL.0b013e3181e0f17a.

15.

Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.

Elterman RD, Shields WD, Bittman RM, Torri SA, Sagar SM, Collins SD.

J Child Neurol. 2010 Nov;25(11):1340-7. doi: 10.1177/0883073810365103.

PMID:
20404353
16.

Language and brain volumes in children with epilepsy.

Caplan R, Levitt J, Siddarth P, Wu KN, Gurbani S, Shields WD, Sankar R.

Epilepsy Behav. 2010 Mar;17(3):402-7. doi: 10.1016/j.yebeh.2010.01.009.

17.

Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex.

Wu JY, Salamon N, Kirsch HE, Mantle MM, Nagarajan SS, Kurelowech L, Aung MH, Sankar R, Shields WD, Mathern GW.

Neurology. 2010 Feb 2;74(5):392-8. doi: 10.1212/WNL.0b013e3181ce5d9e.

18.

Amygdala volumes in childhood absence epilepsy.

Schreibman Cohen A, Daley M, Siddarth P, Levitt J, Loesch IK, Altshuler L, Ly R, Shields WD, Gurbani S, Caplan R.

Epilepsy Behav. 2009 Nov;16(3):436-41. doi: 10.1016/j.yebeh.2009.08.009.

PMID:
19766541
19.

Benign epilepsy with centrotemporal spikes.

Shields WD, Snead OC 3rd.

Epilepsia. 2009 Sep;50 Suppl 8:10-5. doi: 10.1111/j.1528-1167.2009.02229.x.

20.

Frontal and temporal volumes in Childhood Absence Epilepsy.

Caplan R, Levitt J, Siddarth P, Wu KN, Gurbani S, Sankar R, Shields WD.

Epilepsia. 2009 Nov;50(11):2466-72. doi: 10.1111/j.1528-1167.2009.02198.x.

Items per page

Supplemental Content

Loading ...
Support Center